McEwen Inc. (MUX) stock analysis
Close on Nov 12, 2026Market cap $733.24MP/E 20.6Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Weak7 of 30 checks passed
McEwen passes 7 of the 30 checks behind our score; 18 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 2/6
- Growth
- 3/6
- Past performance
- 0/6
- Financial health
- 2/6
- Dividend
- 0/6
What stands out
Trading below fair value
The share price of $12.71 is below our fair value estimate of $13.97.
Revenue growing 10%+ a year
Revenue grew 21.4% a year over the last three fiscal years.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 24.9% of total debt.
Guidance raised
McEwen raised its Full Year 2026 AISC/GEO outlook on Aug 7, 2026.
What to watch
Margin of safety under 20%
The price is 9.0% below fair value, less than the 20% cushion we look for.
Elevated bankruptcy risk
The Altman Z-score is 0.18; above 3 is the safe zone and below 1.8 the distress zone.
P/E above the industry
McEwen's P/E of 21.9 is above the Materials median of 21.9.
Growing slower than the industry
Revenue grew 45.1% over the last twelve months; the Materials median is 46.4%.
Valuation2/6
P/E against its history
Not enough price and earnings history to compare.
P/E above the industry
McEwen's P/E of 21.9 is above the Materials median of 21.9.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/S below the industry
McEwen's price-to-sales of 3.23 is below the Materials median of 5.46 (book value is negative, so we use sales).
Trading below fair value
The share price of $12.71 is below our fair value estimate of $13.97.
Margin of safety under 20%
The price is 9.0% below fair value, less than the 20% cushion we look for.
Growth3/6
Revenue growing 10%+ a year
Revenue grew 21.4% a year over the last three fiscal years.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 45.1% over the last twelve months; the Materials median is 46.4%.
Guidance raised
McEwen raised its Full Year 2026 AISC/GEO outlook on Aug 7, 2026.
Gross margin improving
Gross margin was 30.2% over the last twelve months, against 18.3% a year earlier.
Past performance0/6
Return on equity
Needs positive equity and five years of results.
Return on invested capital
Needs operating income and invested capital.
Return on equity against the industry
Needs positive equity.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health2/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 24.9% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 1.34 times current liabilities.
Elevated bankruptcy risk
The Altman Z-score is 0.18; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
McEwen has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$13.97
The share price is 9% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 21.9× | – | 21.9× | $12.71 | 53% |
| EV/EBITDA | 12.8× | – | 12.8× | $15.41 | 47% |
| Fair value | $13.97 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Materials median 21.9
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $16.16M
- Value traded per 1% price move
- $5.79M
Downside
High risk
- Typical loss in a bad month
- 30.2%
- Volatility (annualized)
- 66%
- Sharpe ratio, 1 year
- -0.45
- Beta to the S&P 500 (5Y)
- 1.48
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +13.2% | +21.4% | +13.5% | +10.5% | |
| Gross profit | +53.8% | – | – | +2.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 4.9% | -35.2% | – | |
| Return on assets | 4.3% | -26.9% | -0.2% | |
| Current ratio | 3.82 | 1.17 | 1.69 | |
| Net debt to EBITDA | – | – | 2.46× | |
| Inventory turnover | 1.4× | 4.0× | 6.7× | |
| Capex to revenue | 1.9% | – | – | |
| Diluted shares | 30M | 40M | 66M |
Cash use needs five years of cash flow figures
McEwen does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2020 | -145.4% | 0.19× | 1.31× | -35.2% |
| FY2019 | -51.1% | 0.19× | 1.27× | -12.1% |
| FY2018 | -35.0% | 0.21× | 1.20× | -8.9% |
| FY2017 | -15.8% | 0.12× | 1.13× | -2.2% |
| FY2016 | 34.9% | 0.12× | 1.13× | 4.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero-$1.26M
- Cash generatingOperating cash flow above zero$6.87M
- Return on assets improvedROA up on the prior year-6.6% → -0.2%
- Earnings backed by cashOperating cash flow above net income$6.87M vs -$1.26M
- Less leverageLong-term debt to assets fell6.0% → 15.4%
- Better liquidityCurrent ratio rose0.86 → 1.69
- No dilutionShare count did not rise51M → 66M
- Gross margin improvedGross margin up on the prior year17.73% → 24.08%
- More efficientAsset turnover rose0.27 → 0.30
See a number that looks wrong?